Combined Use of Clinical and Pathologic Staging Variables to Define Outcomes for Breast Cancer Patients Treated With Neoadjuvant Therapy [PDF]
Jacqueline S. Jeruss+9 more
openalex +1 more source
Predictors of disease-free and overall survival in retroperitoneal sarcomas: A modern 16-year multi-institutional study from the United States Sarcoma Collaboration (USSC) [PDF]
al., et+2 more
core +1 more source
Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall‐cell lung cancer [PDF]
Allen M. Chen+4 more
openalex +1 more source
Prospects for the application of pathological response rate in neoadjuvant therapy for gastric cancer. [PDF]
Bao Z+5 more
europepmc +1 more source
Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST. [PDF]
Mohammadi M+13 more
europepmc +1 more source
A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer [PDF]
L. van de Schoot+7 more
openalex +1 more source
Mucosal Microbiome Markers of Complete Pathologic Response to Neoadjuvant Therapy in Rectal Carcinoma. [PDF]
Abukhiran IM+3 more
europepmc +1 more source
Neoadjuvant Docetaxel and Cisplatin followed by Concurrent Cisplatin with Radiation Therapy in Treatment of Locally Advanced Nasopharyngeal Carcinoma [PDF]
Ehab Hassan, Ahmed Fathi
openalex +1 more source
Adjuvant and neoadjuvant therapy with lapatinib in ErbB2-overexpressing breast cancer [PDF]
Janni, Wolfgang+3 more
core +2 more sources